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Abstract
Although astrocytes are the most abundant cell type in the central nervous system (CNS), little is known about their
molecular specification and differentiation. It has previously been reported that transcription factor Nkx6.1 is expressed in
neuroepithelial cells that give rise to astrocyte precursors in the ventral spinal cord. In the present study, we systematically
investigated the function of Nkx6.1 in astrocyte development using both conventional and conditional Nkx6.1 mutant mice.
At early postnatal stages, Nkx6.1 was expressed in a subpopulation of astrocytes in the ventral spinal cord. In the
conventional Nkx6.1KO spinal cord, the initial specification of astrocyte progenitors was affected by the mutation, and
subsequent migration and differentiation were disrupted in newborn mice. In addition, the development of VA2 subtype
astrocytes was also inhibited in the white matter. Further studies with Nkx6.1 conditional mutants revealed significantly
delayed differentiation and disorganized arrangement of fibrous astrocytes in the ventral white matter. Together, our
studies indicate that Nkx6.1 plays a vital role in astrocyte specification and differentiation in the ventral spinal cord.
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Introduction
Astrocytes and oligodendrocytes are macroglial cells found in all
regions of the central nervous system (CNS). It is estimated that
macroglial cells constitute as many as 90% of cells in some regions
of the CNS, with astrocytes being the predominant cell type.
Although both glial cell types act to support the activities of
neurons, oligodendrocytes and astrocytes have clearly distinct
functions. The primary function of an oligodendrocyte is to form
myelin sheaths around multiple axons for rapid transmission of
electrical pulses along axons. In contrast, astrocytes play many
diverse roles, both supportive and active, in the functioning of the
CNS. Among those are the regulation of ion and neurotransmitter
concentrations, formation of the brain blood barrier, modulation
of synapse formation and efficacy [1], and induction of neuro-
genesis in the adult brain [2]. Thus, it is unsurprising that
abnormalities in astrocyte density and functioning have recently
been implicated in several common neurological diseases including
neuropathic pain, depression, and schizophrenia [3,4].
Spinal cord has served as an excellent model system to study the
origin and molecular specification of neurogenesis and gliogenesis
due to its relatively simple anatomy and structures. In the
developing spinal cord, neuroepithelial cells in the ventricular zone
(VZ) first give rise to neurons which subsequently migrate away
from the ventricular zone by radial migration. At later stages,
neuroepithelial cells switch to produce glial cells, i.e. astrocytes or
oligodendrocytes. In the past decade, great progress has been
made in our understanding of the origin and molecular control of
oligodendrocyte development. During gliogenesis, early oligoden-
drocyte progenitor cells (OPCs) originate from the ventral motor
neuron progenitor domain (pMN) of the ventral neuroepithelium
[5,6], but a small number of OPCs are also generated from dorsal
neural progenitor cells at later stage [7,8]. Recent molecular and
genetic evidence suggests that astrocytes are produced from other
domains of neural progenitor cells, particularly from the p1-p3
domains in the ventral spinal cord [9,10]. Although considerable
progress has been made in our understanding of the molecular
specification of oligodendrocytes, the molecular mechanisms that
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control the development of astrocytes have been lagging, partly
due to the lack of well-defined stage-specific markers for astrocyte
lineage.
Previous studies have demonstrated that the Nkx6.1 homeodo-
main transcription factor is widely expressed by neural progenitor
cells within the ventral neural tube and it plays a prominent role in
ventral neural patterning and neurogenesis [11-13]. During
gliogenesis, Nkx6.1 expression is retained in neuroepithelial cells
in the ventricular zone (VZ), including the progenitor cells that
produce astrocyte precursors [14]. More recently, it has been
shown that the identity of positionally distinct ventral astrocyte
subtypes (VAs) is determined by Nkx6.1 [15]. In this study, we
showed that Nkx6.1 is selectively expressed by ventral astrocytes
after they migrate away from the VZ to the surrounding
parenchyma. Nkx6.1 ablation leads to abnormal specification,
delayed differentiation and disorganized morphology of ventral
astrocytes, indicating an important role for Nkx6.1 in the
development of astrocytes in the ventral spinal cord.
Materials and Methods
Animals
Mice used in this study were handled according to the protocols
approved by Institutional Animal Care and Use Committee
(IACUC), University of Louisville (IACUC: 12034). C57BL/6N
mice were obtained from Jackson Laboratory. The Nkx6.1
homozygous null (KO) embryos were obtained by the interbreed-
ing of double heterozygous animals. For generation of tissue-
specific Nkx6.1 conditional mutant mice, Nkx6.1 conditional
knockout hGFAPCre/+;Nkx6.1flox/flox mice were bred with the
hGFAPCre line to generate tissuespecific Nkx6.1-knockout mice.
For mouse genotyping, genomic DNA was extracted from
embryonic tissues or mouse tails and subsequently used for
genotyping by Southern analysis or PCR. Genotyping protocols
for Nkx6.1KO mouse line was described in Sander et al. [16], and
genotyping protocol for hGFAPCre and Nkx6.1flox mouse lines was
described previously [17,18]. For statistical analyses of cell number
and relative expression level of target proteins was calculated from
each genotype animals (n = 3).
Figure 1. Nkx6.1 expression in ventral spinal cord astrocytes. A-E: Transverse sections from wild-type mice spinal cord at early postnatal
stages were double immunostained with anti-Nkx6.1 in conjunction with anti-Olig2, anti-Sox10, anti-BLBP, anti-GFAP, or anti-GS. Double-positive cells
are represented by arrows. Orthogonal reconstructions of confocal images at z-axis level are shown in side panels (along the right-hand edge and
beneath). Note that all Nkx6.1+ cells in ventral white matter (WM) co-express GFAP. F-G: Spinal cord sections from P4 wild-type animal were
subjected to Fgfr3 (blue) ISH followed by anti-Nkx6.1 (brown) immunostaining. Representative double positive cells in WM and gray matter (GM) are
indicated by red arrows. The insets are the higher magnification of double positive cells. H-I: Transverse sections from wild-type mice spinal cord at
P0 were double immunostained with anti-Nkx6.1 and anti-Iba1 or anti-NeuN antibodies. Arrows represent double-positive cells in GM. Scale bars
50 mm.
doi:10.1371/journal.pone.0109171.g001
Figure 2. Abnormal S100B expression in Nkx6.1 mutant spinal
cord. Spinal cord sections from E15.5 (A-B) and E18.5 (C-D) wild-type (A,
C) and Nkx6.12/2 (B, D) embryos were immunostained with anti-S100B.
S100B expression was dramatically reduced in the ventricular zone
(arrowhead), but increased in the floor plate (arrow) in the mutants.
Scale bar: 100 mm.
doi:10.1371/journal.pone.0109171.g002
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In Situ RNA Hybridization and immunofluorescence
staining
In situ hybridization (ISH) was performed according to
Schaeren-Wiemers and Gerfin-Moser [19] with minor modifica-
tions. Animals were deeply anesthetized and perfused with 4%
paraformaldehyde (PFA), and tissues were isolated and postfixed in
4% PFA at 4uC overnight. Fixed spinal cord tissues were
embedded in OCT medium and sectioned on a cryostat. Frozen
sections (16 mm thick) were subjected to ISH with digoxigenin-
labeled riboprobes. Double immunofluorescent procedures were
described previously [7]. The dilution ratio of antibodies is as
follows: anti-S100B (Millipore Bioscience Research Reagents,
1:1000), anti-GS (Sigma, 1:500), anti-BLBP (Abcam, 1:500), anti-
Olig2 (Abcam, 1:3000), anti-NeuN (Abcam, 1:100), anti-Iba1
(Wako, 1:500), anti-Sox10 (1:3000, kind gift of Dr. Michael
Wegner), anti-GFAP (Millipore Bioscience Research Reagents,
1:500), anti-Nkx6.1 (Developmental Studies Hybridoma Bank,
University of Iowa, Iowa City, IA; 1:50) [20]. For ISH
experiments, tissues were hybridized with digoxigenin-labeled
Fgfr3, Glast, GFAP, Reelin and Slit1 riboprobes. For double
labeling experiments, tissues were first subjected to RNA in situ
hybridization (ISH) with Fgfr3 riboprobe, followed by anti-Nkx6.1
immunohistochemical staining with ABC kit as described previ-
ously [21].
Figure 3. Delayed migration of astrocyte progenitors in Nkx6.1mutant spinal cord. A-H9: Transverse spinal cord sections from E12.5 (A-B9),
E14.5 (C-D9), E16.5 (E-F9) and E18.5 (G-H9) wild-type and mutant embryos were subjected to ISH with riboprobes for Fgfr3 and Glast. I: The number of
Fgfr3+ or Glast+ cells migrated out from VZ in the control and Nkx6.1 mutant spinal cord at E14.5. Error bar, standard deviation (n = 3, **P,0.01). In
Nkx6.1 mutants, the early expression of Fgfr3 and Glast in the ventral ventricular zone is not affected, but the migration of progenitor cells is
significantly delayed at E14.5 although it is recovered at E18.5. Scale bar: 100 mm.
doi:10.1371/journal.pone.0109171.g003
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Western blotting
Spinal cord tissues were lysed in tissue lysis buffer (Sigma) with
protease inhibitor cocktail (Sigma). 30 ng protein from control and
mutant tissues was loaded for SDS-PAGE electrophoresis and
subsequently detected with anti-Olig2 (Abcam, 1:10000) anti-
GFAP (Millipore Bioscience Research Reagents), anti-Nkx6.1
(DSHB Inc.), and mouse anti-GAPDH (Sigma, 1:5000) antibodies
according to the standard protocol. The optical density of blots on
films was assessed with the analysis tool in Quantity One software
of BIO-RAD ChemiDoc XRS (Biorad, USA) and the relative
densitometric values were used for statistical analyses on the
expression level of target proteins.
Primary Astrocyte culture and Nkx6.1 knockdown in vitro
Cerebral cortices from P0 s.d. rats were dissected out, minced
and digested in 0.25% trypsin at 37uC. The digestion was stopped
by the addition of Dulbecco’s modified Eagle’s medium (DMEM)/
F12 containing 10% fetal bovine serum (FBS). The dissociated
cells were plated in a 75 cm2 tissue culture flask coated with
100 mg/ml poly-L-lysine, and the whole medium was changed
next day. After 10 days’ culture, the cells were rinsed three times
with culture medium and pre-shaken for 1 hour at 200 rpm to
remove microglia. Then flasks were sealed and shaken at 250 rpm
at 37uC for 15–18 hours to remove oligodendrocyte precursor
cells. The medium with the detached cells was collected and first
plated on tissue culture dishes (non PDL coated) for 30–60 minutes
at 37uC with a gentle swirling of the dishes to eliminate
contaminating dead cells and residual microglia. The nonadherent
cells were collected, centrifuged and replated in DMEM contain-
ing 10% FBS.
For Nkx6.1 knockdown experiments, small interfering RNA for
Nkx6.1 (siRNA-Nkx6.1) was prepared by GenePharma (Shanghai,
China). The siRNA-Nkx6.1 sequence was 59-GGA GAA GAC
UUU CGA ACA ATT UUG UUC GAA AGU CUU CUC
CTT. Purified astrocytes were transfected with siRNA-Nkx6.1 6 h
before experiments using Lipofectamine 2000 according to the
manufacturer’s guidelines.
RNA Preparation and Real-Time PCR
mRNA levels were assessed by real-time PCR using an Bio-Rad
QX100 Droplet Digital PCR system (USA). cDNA was synthe-
sized by Mol Neurobiol reverse transcription using oligo (dT) as
the primer and proceeded to real-time PCR with gene-specific
primers in the presence of SYBR Premix Ex Taq (DRR041A,
Takara Biotechnology, Dalian, China). Quantification was per-
formed by the comparative cycle threshold (Ct) method, using b-
actin as the internal control. The following forward (F) and reverse
(R) primers were used to amplify: GFAP-F: 59-CCA CCA GTA
ACA TGC AAG AAA CA-39, GFAP-R: 59-CAG TTG GCG
GCG ATA GTC A-39, STAT3-F: 59-GCA TTC GGA AAG
TAT TGT CGC-39, STAT3-R: 59-ATC GGC AGG TCA ATG
GTA T-39, Olig2-F: 59-GCT GTG GAA ACA GTT TGG GT-
39, Olig2-R: 59-AAG GGT GTT ACA CGG CAG AC-39, b-
actin-F: 59-CGC ACC ACT GGC ATT GTC AT-39, b-actin-R:
59-TTC TCC TTG ATG TCA CGC AC-39.
Statistical Analysis
Statistical differences were determined by Student’s t test for
two-group comparison or by one-way ANOVA followed by
Tukey’s post hoc test for multiple comparisons. The accepted level
of significance was P,0.05. Data in the text and figures are
presented as mean6SEM.
Results
Nkx6.1 is selectively expressed in ventral gray and white
matter astrocytes
Nkx6.1 is widely expressed by neural progenitor cells within the
ventral neural tube throughout embryogenesis [11–14]. As the
majority of ventral domains contribute to astrogliogenesis, it is
likely that the Nkx6.1 may regulate astrocyte development in the
spinal cord. Immunostaining in postnatal mouse spinal cords
revealed scattered Nkx6.1-expressing cells in the ventral spinal
cords of early postnatal stages. Double immunostaining in
postnatal spinal cord revealed that Nkx6.1+ cells did not co-
express the oligodendrocytes markers Olig2 and Sox10, nor the
microglia marker Iba1 (Figure 1A, B, H). Instead, they co-
expressed the astrocytic progenitor markers BLBP and Fgfr3 [22–
24] (Figure 1C, F, G). Detailed analysis revealed that Nkx6.1+
nuclei were localized in GS+ protoplasmic astrocytes and in a few
NeuN+ neurons in the ventral gray matter (Figure 1E, I), and were
intimately associated with GFAP+ fibrous astrocytic processes in
the white matter (Figure 1D). These expression studies demon-
strate that during gliogenesis stage, Nkx6.1 is specifically expressed
Figure 4. Defective differentiation of fibrous astrocytes in the
ventral white matter of Nkx6.1 mutant spinal cord. Spinal cord
sections from E18.5 wild-type and Nkx6.1 mutants are subjected to ISH
with GFAP riboprobes (A, B), or immunostaining with anti-GFAP (C-F) or
anti-GS (G, H). In Nkx6.1 mutants, GFAP expression was reduced in the
ventral, but not dorsal white matter. Strong GS signal was observed in
the ventral gray matter of spinal cord, and no significant difference was
detected between control and mutant tissues (G, H). Arrows indicate
the reduced GFAP staining in the mutant tissues. Scale bars: 100 mm.
doi:10.1371/journal.pone.0109171.g004
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in the astrocyte lineage, but not in the oligodendrocyte lineage in
the developing spinal cord.
Nkx6.1 is required for the migration of astrocyte
progenitors
To investigate the function of Nkx6.1 in regulating astroglio-
genesis in the ventral spinal cord, we first examined the effect of
Nkx6.1 null mutation on the expression of S100b, an early
astroglial marker expressed in the VZ [25]. At embryonic day 15.5
(E15.5), S100b was predominantly expressed in the VZ (Fig 2A).
In Nkx6.1 mutant, ventricular expression of S100b was dramat-
ically reduced, but its ectopic expression was detected within the
floor plate (Fig 2B). At E18.5, ventricular S100b expression was
still present in the wild-type tissue, but completely vanished in the
mutant spinal cord (Fig 2C-D), suggesting that Nkx6.1 mutation
led to an abnormal fate specification of ventricular neural
progenitor cells.
We next examined the expression of two other astrocytic
progenitor markers, Fgfr3 and Glast [22,26,27] in the ventral
spinal parenchyma by RNA in situ hybridization (ISH). At E12.5,
expression of Fgfr3 and Glast was restricted to the ventricular
zone of the wild-type and Nkx6.1 mutant embryos (Figure 3A-B9).
At E14.5, numerous Fgfr3+ and Glast+ astrocyte progenitors had
migrated out into white matter in control embryos, but few were
seen in the mutants (Figure 3C-D9, I). At later stages, the number
of astrocyte progenitors in the white matter of Nkx6.1 mutants
increased rapidly (Figure 3E-F9). By E18.5, no apparent difference
was found in the wild-type and mutant animals (Figure 3G-H9).
These results suggested that Nkx6.1 is required for the timingly
generation and migration of astrocyte progenitors in the ventral
spinal cord.
Differentiation of fibrous astrocytes in ventral white
matter is retarded in Nkx6.1 mutants
We next assessed whether the differentiation of astrocytes is also
influenced by Nkx6.1 mutation in the ventral spinal cord. GS and
GFAP are lineage-specific markers that label protoplasmic in the
gray matter and fibrous astrocytes in the white matter, respectively
[28,29]. At E18.5, GFAP is largely expressed by fibrous astrocytes
in the ventral white matter in control animals (Figure 4A, E).
However, a marked decrease of GFAP expression was observed in
the ventral white matter of Nkx6.1 mutant mice at both the
mRNA (Figure 4B) and protein levels (Figure 4F). As expected,
expression of GFAP in dorsal spinal cord was not affected by the
mutation (Figure 4C, D). At the same stage, strong GS immuno-
reactivity was observed in the entire gray matter in both the wild-
type and mutant spinal cords, and no significant difference was
detected between these two genotypes (Fig 4G, H).
Since Nkx6.1 mutant animals die immediately after birth due to
defective motor neuron development, it is not clear whether
Figure 5. Delayed differentiation of fibrous astrocytes in Nkx6.1 conditional mutants. A-D9: Spinal cord sections from E18.5 (A-A9), P3 (B–
B9), P5 (C-C9) and P15 (D-D9) wild-type or hGFAPCre;Nkx6.1flox/flox (Cko) conditional mutant embryos were subjected to double immunolabeling with
anti-Nkx6.1 and anti-GFAP. GFAP expression was dramatically reduced in the white matter of Cko spinal cord at E18.5 (A, A9), but mostly recovered at
P15 (D, D9). GFAP+/Nkx6.1+ double positive cells are represented by arrows in the white matter, and arrowheads in the gray matter. The insets in B, C,
and D9 are the higher magnification of cells in the boxes in gray matter. Scale bars: 50 mm. E: Western blotting of E18.5-P5 spinal tissues with
antibodies against Nkx6.1, GFAP or GAPDH. F: Statistical analysis on the relative expression level of GFAP at E18.5, P3 and P5 stages with Student’s t-
test. Error bar, standard deviation (n = 3, **P,0.01, n.s. = no significant).
doi:10.1371/journal.pone.0109171.g005
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Nkx6.1 function is required for postnatal astrocyte development.
Thus, we generated the hGFAPCre;Nkx6.1flox/flox conditional
mice (Cko) in which Nkx6.1 expression was selectively ablated in
the ventricular progenitor cells after neurogenesis [30] (Fig-
ure 5A9-D9). Consistent with the results observed in the Nkx6.1
conventional knockouts, GFAP was significantly reduced in the
ventral white matter of Cko mutants during embryogenesis
(Figure 5A, A9). However, at postanatal stages, expression of
GFAP in Cko mutants increased with time in the white matter
(Figure 5B9, C9, D9), despite the persistently lower level of its
expression than that in the wild-type animal at all stages examined
(Figure 5B, C, D). Western blotting results revealed a similar
reduction of GFAP protein expression in Cko mutant spinal cords
from E18.5 up to postnatal P5 (Figure 5E, F). Together, these
observations suggest that Nkx6.1 ablation results in delayed
expression of GFAP in the ventral spinal cord, indicating that
Nkx6.1 activity is vital for the timely differentiation of GFAP+
astrocytes in this region.
Nkx6.1 knockdown suppress astrocyte differentiation in
culture
To address the cell-autonomous effects of Nkx6.1 deficiency in
astroglia lineage development, cultured astrocytes were treated
with siRNA to suppress Nkx6.1 expression. Consistent with the in
vivo data, the treatment significantly reduced GFAP expression in
primary astrocyte culture (Figure 6A), suggesting an autonomous
role for Nkx6.1 in the regulation of astrocyte differentiation.
Meanwhile, the expression of Olig2 and STAT3 was also reduced
in the astrocytes treated with siRNA-Nkx6.1 (Figure 6B). Since
STAT3 is involved in astrocyte differentiation [31], it has raised
the possibility that Nkx6.1 may regulate astrocyte differentiation
through the JaK/STAT signaling pathway.
Nkx6.1 is required for the generation of VA2 white matter
astrocytes
It has been shown that there are at least three subtypes of white
matter astrocytes in the ventral spinal cord, ventral astrocyte
subtypes 1, 2 and 3 (VA1, VA2 and VA3) that are produced from
p1, p2 and p3 progenitor domains, respectively [15]. It appears
that Nkx6.1 is sufficient for the emergence of Slit1+ VA2 and VA3
Figure 6. Effects of Nkx6.1 knockdown on astrocyte differentiation. A: Astrocytes were transfected with an siRNA-actin (Control) or siRNA-
Nkx6.1 for 6 hours and immunostained with anti-GFAP antibody. Scale bar 100 mm. B: Realtime-PCR analysis of the mRNA levels of Nkx6.1, GFAP,
Olig2 and STAT3 in astrocytes after transfection with Control or siRNA-Nkx6.1. The fluorescent output signal of each gene was measured and
normalized to the corresponding control. (n = 3. *P,0.05. **P,0.01).
doi:10.1371/journal.pone.0109171.g006
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astrocytes; however, it is not clear if Nkx6.1 is required for VA2/3
astrocytes. Thus, we examined the Slit1 expression in the spinal
cord of Nkx6.1KO mice at various embryonic stages. Prior to
gliogenic stages, Slit1 was only expressed in ventricular neural
progenitor cells (Figure 7A, B). At E14.5, many Slit1+ cells had
migrated out into the white matter from p3 domain in the wild-
type embryo; however, fewer Slit1+ cells were detected in the
ventral white matter in the mutants (Figure 7C-F). By E18.5, Slit1
expression was observed in both VA2 and VA3 astrocytes in wild-
type spinal cord, but only in VA3 astrocytes in Nkx6.1 mutants
(Figure 7G, H). These observations suggested that Nkx6.1 is
essential for the development of VA2 white matter astrocytes.
Discussion
The Nkx6.1 homeobox gene is expressed in the ventral neural
progenitor cells that give rise to motor (MN), V2, and V3 neurons
[12,13] and ventral oligodendrocytes [19,30]. Mice carrying
Nkx6.1 null mutation exhibit a ventral-to-dorsal switch in the
identity of progenitor cells with a ventral expansion of V1
interneurons at the expense of MN and V2 neurons [16]. During
gliogenesis, it causes a significant delay in OPC specification and
differentiation [32,7]. In this study, we found that Nkx6.1 also
plays a vital role in the development of astrocyte lineage in the
spinal cord. Nkx6.1 is continuously expressed in astrocyte
precursor cells after they migrate from the VZ into the
parenchyma (Figure 1). Similarly, S100B is also expressed by
astroglial progenitor cells in the VZ and immature astrocytes that
are dispersed within the mantle zone (Fig 2) [33,34]. Disruption of
Nkx6.1 lead to a loss or severe reduction of S100B expression in
the VZ at E15.5 and E18.5 stages (Figure 2). The lack of S100B
expression in the mutants strongly suggests that Nkx6.1 plays an
essential role in the fate specification or lineage maintenance of
astrocyte precursors in the ventral VZ. Consistently, we noticed
that the expression of VA2 Slit1 was lost from E16.5 ventral spinal
cord in Nkx6.1 null mice. This finding also indicated that Nkx6.1
is required for the development of VA2 but not VA3 white matter
astrocytes (Figure 7). It has been proposed that co-expression of
Pax6 and Nkx6.1 specifies a VA2 phenotype (Reelin+, Slit1+) [15].
The normal Reelin expression in Nkx6.1 mutant spinal cord
(Figure S1) suggests that VA2 astrocytes may acquire the VA1
phenotype (Reelin+/Slit1-), consistent with the finding that
expression of Nkx2.2 and Pax6 in the VZ were not affected in
the Nkx6.1 mutant [16].
Intriguingly, ectopic expression of S100B was observed in the
floor plate of E15.5 spinal cords (Figure 2B), which may be
caused by the abnormal migration of mis-specified ventricular
cells. Concommitantly, migration of Glast+ and Fgfr3+ astrocyte
progenitors from the ventral ventricular zone into the ventral
parenchyma was also affected and delayed (Figure 3). Expression
of mature astrocyte marker GFAP was also retarded in the
ventral white matter (Figure 4). Moreover, the processes of
GFAP+ fibrous astrocytes in the white matter become irregular
(Figure 3, 4). In support of this notion, siRNA-Nkx6.1 treatment
reduces GFAP expression in primary astrocyte culture in vitro
(Figure 6), suggesting an autonomous role for Nkx6.1 in the
regulation of astrocyte differentiation. Collectively, these obser-
vations demonstrate that Nkx6.1 function is required for the
normal differentiation and morphogenesis of ventral fibrous
astrocytes.
The mechanisms underlying the retarded differention and
maturation of astrocyte progenitor cells are currently unknown.
Previous studies demonstrated that Olig2 function is important for
white matter astrocyte formation in the spinal cord at postnatal
stages [16]. We found that Nkx6.1 mutation leads to reduced
expression of Olig2 in the spinal cord at both embryonic [32] and
early postnatal stages (Figure S2), it is plausible that the defective
astrocyte specification and differentiation in Nkx6.1 mutants may
be caused by reduction in Olig2 expression. Consistently,
inhibition of Olig2 expression was also observed in primary
astrocytes when Nkx6.1 expression is knocked down (Figure 6B).
Moreover, the expression of STAT3 was also reduced in the
astrocytes treated with siRNA-Nkx6.1 (Figure 6B). It raised the
possibility that Nkx6.1 regulated astrocyte differentiation through
the JaK/STAT signaling pathway, given that STAT3 is required
for astrocyte differentiation [31].
Supporting Information
Figure S1 Normal Reelin expression in spinal cords at
embryo stages of Nkx6.1 mutant. Spinal cord sections from
E12.5, E14.5, E16.5 and E18.5 were subjected to ISH with Reelin
riboprobe in WT and Nkx6.12/2 mice. Reelin was similarly
expressed in WT and Nkx6.12/2 mice at all stages (A-H). I,J:
Figure 7. Abnormal Slit1 expression in spinal cords at embryo
stages of Nkx6.1 mutant. Spinal cord sections from E12.5 to E18.5
embryos were subjected to ISH with Slit1 riboprobe in WT and Nkx6.12/
2 mice. Slit1 expression in the ventral white matter was significantly
reduced at E16.5. At E18.5, Slit1 expression was observed in the ventral
astrocyte subtypes 2 and 3 (VA2 and VA3) in wild-type embryos, but
only in VA3 astrocytes in Nkx6.1 mutants (outlined by dashed lines in G-
H). Scale bars: 100 mm.
doi:10.1371/journal.pone.0109171.g007
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The insets are the higher magnification of ventral astrocyte
subtypes 2 (VA2) of WT and Nkx6.12/2 spinal cord at
E18.5.Scale bars: 100 mm.
(TIF)
Figure S2 Reduced Olig2 expression in postnatal
Nkx6.1 conditional mutant spinal cord. A-H: Transverse
spinal cord sections from E18.5 (A, B), P0 (C, D) P5 (E, F) and P10
(G, H) wild-type and Nkx6.1 Cko embryos were subjected to
immunostaining with anti-Olig2. Arrows indicate the white matter
region of the spinal cord. I: Western immunoblotting of E18.5-
P10 spinal tissues with antibody against Olig2 or GAPDH. Scale
bars: 50 mm. J: Statistical analysis on the relative expression level
of Olig2 at E18.5, P3, P5 and P10 stages with Student’s t-test.
Error bar, standard deviation (n= 3, **P,0.01, n.s. = no
significant).
(TIF)
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